PAR — Par Drugs and Chemicals Share Price
0.000.00%
Last trade - 00:00- IN₹1.27bn
- IN₹1.08bn
- IN₹956.40m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.3 | ||
| Price to Tang. Book | 1.3 | ||
| Price to Free Cashflow | 8.69 | ||
| Price to Sales | 1.24 | ||
| EV to EBITDA | 4.63 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 19.49% | ||
| Return on Equity | 17.59% | ||
| Operating Margin | 19.27% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 558.49 | 607.51 | 750.74 | 957.49 | 956.4 | n/a | n/a | 15.6% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +37.68 | +111.57 | -54.12 | +21.82 | +29.11 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Par Drugs and Chemicals Limited is an India-based company engaged in manufacturing of active pharma ingredients (APIs) and fine chemicals for the domestic market as well as for exports to international markets. The Company manufactures a diverse range of antacid molecules. The Company’s products include magnesium hydroxide, magnesium trisilicate, magnesium carbonate, light magnesium oxide, magnesium oxide heavy, magnesium oxide USP, dried aluminum hydroxide gel, magaldrate, magnesium aluminum silicate hydrated, alma gate, hydrotalcite, aluminum hydroxide magnesium carbonate co-dried gel, aluminum-magnesium silicate BP, sodium aluminum silicate, precipitated silica, magnesium silicate, amorphous, colloidal silicon dioxide, and sucralfate USP. The Company owns and operates its manufacturing facilities at Bhavnagar in Gujarat. It has over four manufacturing blocks at Bhavnagar, which are for different products, having a capacity of approximately 9,700 metric tons per annum.
Directors
- Falgun Savani CHM (45)
- Jignesh Savani CEO (42)
- Chintan Chauhan CFO (37)
- Sanket Trivedi CCO (30)
- Ghanshayambhai Savani EDR (51)
- Naynaben Savani NED (41)
- Shilpa Savani NED (42)
- Pravin Bhayani NID (48)
- Krishna Shah NID (40)
- Kajal Vaghani NID (40)
- Last Annual
- March 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- February 26th, 1999
- Public Since
- May 16th, 2019
- No. of Shareholders
- 7,521
- No. of Employees
- 122
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- National Stock Exchange of India
- Shares in Issue
- 12,304,636
- Address
- 816, Nilamber Triumph,, Gotri Vasna Road, VADODARA, 390007
- Web
- https://pardrugs.com/
- Phone
- +91 2652991022
- Contact
- Sanket Trivedi
- Auditors
- M/S SARUPRIA SOMANI & ASSOCIATES
Upcoming Events for PAR
Q1 2026 Par Drugs and Chemicals Ltd Earnings Release
Q2 2026 Par Drugs and Chemicals Ltd Earnings Release
Similar to PAR
Aarey Drugs and Pharmaceuticals
National Stock Exchange of India
Aarti Drugs
National Stock Exchange of India
Aarti Pharmalabs
National Stock Exchange of India
Abbott India
National Stock Exchange of India
Accent Microcell
National Stock Exchange of India
FAQ
What is the Par Drugs and Chemicals share price?
As of Today at 22:33 UTC, shares in Par Drugs and Chemicals are trading at IN₹102.47. This share price information is delayed by 15 minutes.
How has the Par Drugs and Chemicals share price performed this year?
Shares in Par Drugs and Chemicals last closed at IN₹102.47 and the price had moved by -62.89% over the past 365 days. In terms of relative price strength the Par Drugs and Chemicals share price has underperformed the S&P BSE 100 Index by -65.04% over the past year.
What are the analyst and broker recommendations for Par Drugs and Chemicals?
There is no consensus recommendation for this security.
Find out moreWhat is the Par Drugs and Chemicals dividend yield?
Par Drugs and Chemicals does not currently pay a dividend.
Does Par Drugs and Chemicals pay a dividend?
Par Drugs and Chemicals does not currently pay a dividend.
When does Par Drugs and Chemicals next pay dividends?
Par Drugs and Chemicals does not currently pay a dividend.
How do I buy Par Drugs and Chemicals shares?
To buy shares in Par Drugs and Chemicals you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Par Drugs and Chemicals?
As of the previous close price of IN₹102.47, shares in Par Drugs and Chemicals had a market capitalisation of IN₹1.27bn.
Where are Par Drugs and Chemicals shares listed?
Here are the trading details for Par Drugs and Chemicals:
- Country of listing: India
- Exchange: NSI
- Ticker Symbol: PAR
What kind of share is Par Drugs and Chemicals?
Based on an overall assessment of its quality, value and momentum Par Drugs and Chemicals is currently classified as a Contrarian. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Par Drugs and Chemicals share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Par Drugs and Chemicals share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Par Drugs and Chemicals. Over the past six months, its share price has underperformed the S&P BSE 100 Index by -61.87%.
As of the last closing price of IN₹102.47, shares in Par Drugs and Chemicals were trading -50.24% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Par Drugs and Chemicals PE Ratio?
The Par Drugs and Chemicals PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹102.47.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Par Drugs and Chemicals?
Par Drugs and Chemicals' management team is headed by:
- Falgun Savani - CHM
- Jignesh Savani - CEO
- Chintan Chauhan - CFO
- Sanket Trivedi - CCO
- Ghanshayambhai Savani - EDR
- Naynaben Savani - NED
- Shilpa Savani - NED
- Pravin Bhayani - NID
- Krishna Shah - NID
- Kajal Vaghani - NID